HIKMA PHARMACEUTICALS USA INC.

Hikma Pharmaceuticals USA Inc. specializes in the manufacturing of sterile injectables and oral pharmaceutical preparations for federal medical supply chains, with deep expertise in aseptic processing, formulation development, and cGMP-compliant production of active pharmaceutical ingredients. The company delivers critical medications including phenylephrine vials, lidocaine viscous solutions, doxycycline tablets, and hydralazine HCl injections—products essential for emergency medicine, anesthesia, and infectious disease management in military and veteran care settings. Their technical capabilities encompass end-to-end pharmaceutical manufacturing, from raw material sourcing through final product sterility testing, with demonstrated proficiency in complex dosage forms requiring precise stability and packaging controls. The contractor maintains a sustained relationship with the Department of Defense and the Department of Veterans Affairs, consistently supplying high-priority therapeutics for battlefield medicine, trauma care, and chronic condition management within VA healthcare systems. These agencies rely on Hikma for reliable, scalable production of time-sensitive, mission-critical medications under strict regulatory and logistical constraints. Hikma’s primary industry focus lies in medicinal and botanical manufacturing (NAICS 325411) and pharmaceutical preparation manufacturing (NAICS 325412), positioning them as a specialized supplier of branded and generic injectables and oral solids within the federal healthcare market. Their vertical specialization includes cardiovascular agents, antibiotics, and anesthetics—therapeutic categories with high demand in DoD and VA operational environments. As a 2L entity headquartered in Berkeley Heights, New Jersey, Hikma operates as a vertically integrated pharmaceutical manufacturer without active government certifications. Their geographic presence supports direct distribution to federal medical depots and military treatment facilities, reinforcing their role as a trusted source for mission-critical pharmaceuticals in national defense and veteran health systems.